To determine how loss of Fgfr2 impacts the cell populations identified by scRNA-seq, we examined changes in cluster-enriched gene expression in the developing AF at E18.5 using RNAScope in situ hybridization. The gene discussed is FGFR2; the disease is atrial fibrillation.